コンテンツへスキップ

CrestecBio|News

  • Home
News

CrestecBio Inc. was adopted for the 2022 Ibaraki Prefecture Venture Business Growth Promotion Project (Growth Program).

Bynews

8月 10, 2022

投稿ナビゲーション

Company home page is now open.
Our project was adopted as a candidate for the Strategic Innovation Program (SIP).

By news

Related Post

News

Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan.

5月 25, 2025 news_en
News

Our CEO, Dr. Marushima will attend The 31st Annual Meeting of the Japanese Society for Endovascular Intervention.

5月 16, 2025 news_en
News

An interview with our CEO, Marushima, has been featured on the “Startup Magazine” website by Startup Class Inc. (in Japanese)

5月 12, 2025 news_en

Recent Posts

  • Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan.
  • Our CEO, Dr. Marushima will attend The 31st Annual Meeting of the Japanese Society for Endovascular Intervention.
  • An interview with our CEO, Marushima, has been featured on the “Startup Magazine” website by Startup Class Inc. (in Japanese)
  • Our CEO, Dr. Marushima, will attend BIO International Convention 2025 in Boston.
  • Dr. Marushima presented at Tokyo Investors Night.

見逃しています

News

Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan.

2025-05-25 news_en
News

Our CEO, Dr. Marushima will attend The 31st Annual Meeting of the Japanese Society for Endovascular Intervention.

2025-05-16 news_en
News

An interview with our CEO, Marushima, has been featured on the “Startup Magazine” website by Startup Class Inc. (in Japanese)

2025-05-12 news_en
News

Our CEO, Dr. Marushima, will attend BIO International Convention 2025 in Boston.

2025-05-10 news_en

CrestecBio|News

  • Home